CAREMM-2306: Advanced Immunotherapy vs. Classical Immunotherapy

Active, not recruitingOBSERVATIONAL

Enrollment

2,500

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Lymphoma

Interventions

DRUG

Immunotherapy

Trial Locations (1)

Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul

All Listed Sponsors

lead

Seoul St. Mary's Hospital

OTHER

NCT06202885 - CAREMM-2306: Advanced Immunotherapy vs. Classical Immunotherapy | Biotech Hunter | Biotech Hunter